IL-25 Inhibits Atherosclerosis Development in Apolipoprotein E Deficient Mice.
Mantani, Polyxeni LU ; Dunér, Pontus LU ; Bengtsson, Eva LU
; Alm, Ragnar
LU
; Ljungcrantz, Irena
LU
; Söderberg, Ingrid
LU
; Sundius, Lena
LU
; To, Fong
LU
; Nilsson, Jan
LU
and Björkbacka, Harry
LU
, et al.
(2015)
In PLoS ONE
10(1).
- Abstract
- IL-25 has been implicated in the initiation of type 2 immunity and in the protection against autoimmune inflammatory diseases. Recent studies have identified the novel innate lymphoid type 2 cells (ILC2s) as an IL-25 target cell population. The purpose of this study was to evaluate if IL-25 has any influence on atherosclerosis development in mice.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/5039341
- author
- Mantani, Polyxeni
LU
; Dunér, Pontus
LU
; Bengtsson, Eva
LU
; Alm, Ragnar
LU
; Ljungcrantz, Irena
LU
; Söderberg, Ingrid
LU
; Sundius, Lena
LU
; To, Fong
LU
; Nilsson, Jan
LU
and Björkbacka, Harry
LU
, et al. (More)
- Mantani, Polyxeni
LU
; Dunér, Pontus
LU
; Bengtsson, Eva
LU
; Alm, Ragnar
LU
; Ljungcrantz, Irena
LU
; Söderberg, Ingrid
LU
; Sundius, Lena
LU
; To, Fong
LU
; Nilsson, Jan
LU
; Björkbacka, Harry
LU
and Nordin Fredrikson, Gunilla
LU
(Less)
- organization
- publishing date
- 2015
- type
- Contribution to journal
- publication status
- published
- subject
- in
- PLoS ONE
- volume
- 10
- issue
- 1
- article number
- e0117255
- publisher
- Public Library of Science (PLoS)
- external identifiers
-
- pmid:25629516
- wos:000348732100076
- pmid:25629516
- scopus:84922121986
- ISSN
- 1932-6203
- DOI
- 10.1371/journal.pone.0117255
- language
- English
- LU publication?
- yes
- id
- 744be59f-111f-4f04-b6d7-92eda48ba634 (old id 5039341)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/25629516?dopt=Abstract
- date added to LUP
- 2016-04-01 14:20:52
- date last changed
- 2022-04-14 17:16:53
@article{744be59f-111f-4f04-b6d7-92eda48ba634,
abstract = {{IL-25 has been implicated in the initiation of type 2 immunity and in the protection against autoimmune inflammatory diseases. Recent studies have identified the novel innate lymphoid type 2 cells (ILC2s) as an IL-25 target cell population. The purpose of this study was to evaluate if IL-25 has any influence on atherosclerosis development in mice.}},
author = {{Mantani, Polyxeni and Dunér, Pontus and Bengtsson, Eva and Alm, Ragnar and Ljungcrantz, Irena and Söderberg, Ingrid and Sundius, Lena and To, Fong and Nilsson, Jan and Björkbacka, Harry and Nordin Fredrikson, Gunilla}},
issn = {{1932-6203}},
language = {{eng}},
number = {{1}},
publisher = {{Public Library of Science (PLoS)}},
series = {{PLoS ONE}},
title = {{IL-25 Inhibits Atherosclerosis Development in Apolipoprotein E Deficient Mice.}},
url = {{https://lup.lub.lu.se/search/files/3925545/7753904.pdf}},
doi = {{10.1371/journal.pone.0117255}},
volume = {{10}},
year = {{2015}},
}